YTHDF3
YTH domain-containing family protein 3
Also known as: FLJ31657, YTHD3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z739
- Gene
- YTHDF3
- Ensembl
- ENSG00000185728
- Chromosome
- 8
- Canonical length
- 585 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the YTH (YT521-B homology) domain protein family. The YTH domain is common in eukaryotes, is often found in the middle of the protein sequence, and may function in binding to RNA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]
Canonical amino-acid sequenceUniProt
585 residues, UniProt reviewed canonical sequence.
>Q7Z739|YTHDF3
1 MSATSVDQRP KGQGNKVSVQ NGSIHQKDAV NDDDFEPYLS SQTNQSNSYP PMSDPYMPSY
61 YAPSIGFPYS LGEAAWSTAG DQPMPYLTTY GQMSNGEHHY IPDGVFSQPG ALGNTPPFLG
121 QHGFNFFPGN ADFSTWGTSG SQGQSTQSSA YSSSYGYPPS SLGRAITDGQ AGFGNDTLSK
181 VPGISSIEQG MTGLKIGGDL TAAVTKTVGT ALSSSGMTSI ATNSVPPVSS AAPKPTSWAA
241 IARKPAKPQP KLKPKGNVGI GGSAVPPPPI KHNMNIGTWD EKGSVVKAPP TQPVLPPQTI
301 IQQPQPLIQP PPLVQSQLPQ QQPQPPQPQQ QQGPQPQAQP HQVQPQQQQL QNRWVAPRNR
361 GAGFNQNNGA GSENFGLGVV PVSASPSSVE VHPVLEKLKA INNYNPKDFD WNLKNGRVFI
421 IKSYSEDDIH RSIKYSIWCS TEHGNKRLDA AYRSLNGKGP LYLLFSVNGS GHFCGVAEMK
481 SVVDYNAYAG VWSQDKWKGK FEVKWIFVKD VPNNQLRHIR LENNDNKPVT NSRDTQEVPL
541 EKAKQVLKII ATFKHTTSIF DDFAHYEKRQ EEEEAMRRER NRNKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against YTHDF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 86 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 86 nTPM
- liver: 38 nTPM
- tongue: 34 nTPM
- skeletal muscle: 32 nTPM
- placenta: 28 nTPM
- smooth muscle: 27 nTPM
Single-cell type
- neutrophils: 864 nCPM
- neutrophil progenitors: 407 nCPM
- monocytes: 332 nCPM
- macrophages: 211 nCPM
- endometrial glandular cells: 202 nCPM
- monocyte progenitors: 170 nCPM
Immune cell
- non-classical monocyte: 48 nTPM
- basophil: 41 nTPM
- neutrophil: 37 nTPM
- intermediate monocyte: 33 nTPM
- eosinophil: 31 nTPM
- classical monocyte: 29 nTPM
Brain region
- choroid plexus: 46 nTPM
- cerebellum: 45 nTPM
- thalamus: 44 nTPM
- cerebral cortex: 43 nTPM
- basal ganglia: 40 nTPM
- hypothalamus: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.66
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA destabilization
- negative regulation of type I interferon-mediated signaling pathway
- organelle assembly
- positive regulation of translation
- positive regulation of translational initiation
- regulation of mRNA stability
- regulation of trophoblast cell migration
- stress granule assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of YTHDF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads YTHDF3 as an antibody target. Whether an autoantibody or antibody against YTHDF3 could matter depends on whether native YTHDF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
YTHDF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label YTHDF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...